Skip to the page

Data / Form D filings / AZEVAN PHARMACEUTICALS INC

AZEVAN PHARMACEUTICALS INC: Form D filing

AZEVAN PHARMACEUTICALS INC, a pharmaceuticals company in Bethlehem, PA, filed a Form D with the SEC in 2013. The latest, on October 18, 2013, reports $2.2 million sold of a $6.5 million offering to 4 investors.

Find out what AZEVAN PHARMACEUTICALS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
116 RESEARCH DRIVE, Bethlehem, PA, 18015
Phone
(610) 419-1057
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
Delaware
Revenue range
No Revenues
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1334514

The full lists. Form D filings in Pennsylvania: 987 rows, $49.35, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get the first 200 rows free

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 18, 2013New notice$6,500,000$2,205,000$4,295,0004Oct 4, 2013sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Geoffrey G. SmithDirector
Morton G. HymanDirector
Neal G. SimonExecutive Officer, Director
Mike G. PaviaDirector
Paul J. MaddonDirector
Carter G. MeyerDirector

Other pharmaceuticals companies in Pennsylvania that filed recently

Every Form D from the week of Oct 14, 2013 · All recent filings in Pennsylvania · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what AZEVAN PHARMACEUTICALS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.